Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of nonapeptide-1 serum in China. Welcome to wholesale bulk high quality nonapeptide-1 serum for sale here from our factory. Good service and reasonable price are available.
Nonapeptide-1 serum is a bioactive polypeptide skin brightening essence with Nonapeptide-1 as its core functional ingredient. It selectively resides within the epidermal layer of the skin without penetrating the dermis to trigger excessive cellular stress response. Meanwhile, it efficiently antagonizes the binding of alpha-MSH (melanocyte-stimulating hormone) to the MC1R receptor on melanocytes, blocking melanin production signals at the source and inhibiting melanosome transportation to the stratum corneum to deliver dual-pathway melanin fading and brightening effects.
It delivers stable efficacy in fading stubborn pigmentation and exhibits no photosensitivity, enabling all-day daytime application. Balancing whitening benefits with long-term skin conditioning, it addresses persistent industry pain points of conventional whitening actives-such as high irritation, mandatory light avoidance and post-treatment pigment rebound.
Our Products Form
Nonapeptide-1 COA
Leveraging three core strengths: mild melanin inhibition, superior biocompatibility and wide formulation compatibility, nonapeptide-1 serum has expanded beyond standard facial brightening skincare into three differentiated niche tracks: targeted eye care, skin-nourishing makeup and specialized hair care, filling technical gaps left by traditional cosmetic products for pigmentation, post-makeup skin maintenance and abnormal hair pigmentation issues.
Targeted Eye Care
The product stands as the optimal polypeptide whitening raw material formulated for delicate periorbital skin, featuring two irreplaceable differentiated advantages. First, its mild and non-invasive mechanism suppresses melanin synthesis purely through signal blockade rather than direct damage to melanocytes, eliminating irritation to the fragile periorbital skin barrier. Second, its moderate molecular weight prevents excessive penetration that causes milia buildup, while enabling rapid permeation through the sebum-deficient periorbital barrier to reach pigment deposits in the epidermis.
Compared with conventional eye brightening ingredients, it delivers triple synergistic effects: blocking periorbital alpha-MSH signals to curb new melanin formation, metabolizing aged surface pigment deposits, and repairing mild periorbital inflammation to prevent recurrent pigmentation.
Third-party human clinical test data shows that 28 consecutive nights of application of Nonapeptide-1 specialized eye serum yielded an average 4.92% reduction in color difference values for pigmented dark circles among test subjects, with zero reported adverse reactions including periorbital allergy, stinging or milia breakout.
Skin-Nourishing Makeup
Concealed Brightening & Skin Conditioning Mechanism
It boasts exceptional formulation stability with resistance to high temperature, acid and alkali. It seamlessly integrates with aqueous, oily and powder cosmetic bases without compromising the original coverage, wear resistance and skin feel of foundation, qualifying it as a typical concealed skincare additive.
Its dual-action makeup-skincare integration logic consists of instant surface refinement and long-term deep conditioning: On the surface, its lightweight, translucent texture optimizes powder adhesion to reduce mask-like finish and deliver natural luminous brightening.
Beneath the makeup layer, it sustains melanin-inhibiting activity over 8–10 hours of wear, alleviating oxidative dullness induced by powder friction and external UV exposure, and mitigating sallowness and inflammatory pigmentation stemming from long-term makeup use.
Unlike moisturizing or anti-aging additives common in nourishing makeup, Nonapeptide-1 directly targets the top concerns of frequent makeup wearers-dullness and yellow complexions-achieving instant brightening upon makeup application and sustained whitening after makeup removal.
Mainstream Cosmetic Application Scenarios & Product Advantages
Nonapeptide-1 serum is widely incorporated into three core cosmetic categories: primer essences, skin-nourishing foundations and brightening concealers. A dosage range of 0.2%–1% delivers lasting brightening benefits without altering foundation viscosity or wear longevity.
Clinical trials on chronic makeup wearers demonstrate that 30 days of consistent use of Nonapeptide-1-infused nourishing foundation reduces skin sallowness index by 3.7% and markedly boosts post-cleansing skin translucency, upgrading cosmetics from mere blemish coverage to active blemish correction. Additionally, the ingredient is non-photosensitive, posing no safety risks for daytime foundation formulas and compatible with cosmetic formulations for all seasons.
Niche Application in Hair Care
Unaddressed Pigmentation Challenges in the Hair Care Industry
Public perception commonly associates melanin solely with skin tone, yet melanocyte activity within hair follicles directly dictates hair color. Scalp and hair pigment disorders have grown increasingly prevalent, encompassing post-inflammatory scalp pigmentation, dark hyperpigmentation marks after recurrent hair loss and redness along the hairline, pigment dysregulation in follicles surrounding new gray hair, and uneven pigment distribution on chemically dyed hair strands.
Conventional hair care products primarily focus on smoothness, oil control and dandruff removal, lacking targeted actives to modulate follicular melanocyte activity. No dedicated solutions previously existed for scalp pigmentation and hairline dark marks. Powered by targeted melanin-suppressing properties, the product has successfully entered the underserved blue ocean niche of hair care.
Mechanism of Action on Scalp & Hair
Nonapeptide-1 acts on melanocytes surrounding superficial scalp follicles, blocking excessive alpha-MSH secretion triggered by scalp inflammation to curb abnormal scalp melanin accumulation and fade post-acne scalp discoloration and friction-induced hairline dark marks.
It also gently regulates follicular melanocyte activity to alleviate follicular pigment dysregulation, stabilizing natural hair melanin and mitigating oxidative dryness and color fading of hair strands.
Unlike skin care applications that demand robust melanin fading efficacy, hair care formulations only require low concentrations (0.1%–0.5%) of Nonapeptide-1 to deliver desired conditioning effects. It causes no irritation to delicate scalp follicles and presents no side effects such as scalp itchiness or increased dandruff.
Developed through polypeptide library screening technology and molecular biological research on melanocytes, Nonapeptide-1 underwent three complete phases: fundamental scientific research, target validation and cosmetic raw material commercialization. Its full R&D timeline spans the 1990s to the early 2000s, marking a landmark achievement in targeted whitening polypeptide raw materials.
Fundamental Target Research & Preliminary Polypeptide Screening (1990–1994)
In the early 1990s, the global cosmetic skincare industry faced a bottleneck in whitening active development. Conventional synthetic whitening chemicals carried unavoidable drawbacks including cytotoxicity and photosensitivity, driving academic research toward mild whitening actives derived from endogenous human signaling molecules.
The research team led by Channa K. Jayawickreme at Yale University School of Medicine launched a broad-spectrum polypeptide library screening program, conducting in vitro cellular assays on a total of 31,360 structurally distinct polypeptide compounds. The core screening objective was antagonist polypeptides capable of blocking alpha-MSH-mediated melanin activation signals.
Initially designed to develop antimicrobial polypeptides, the project reached a pivotal turning point when subsequent assays unexpectedly identified potent melanin-modulating activity in certain nonapeptide fragments, laying the groundwork for Nonapeptide-1 development.
Molecular Structure Finalization & Mechanism Validation (1994–1998)
In 1994, the team designed the artificial molecule of Nonapeptide-1 using the 5–13 amino acid sequence of endogenous human alpha-MSH as a template, defining its exclusive peptide chain structure: Met-Pro-D-Phe-Arg-D-Trp-Phe-Lys-Pro-Val-NH₂. The 5th residue D-Trp and 6th residue Phe were verified as core active binding sites.
In vitro cellular testing recorded an MC1R receptor antagonism IC50 value as low as 11.7 nM, indicating ultra-strong targeted binding affinity. In 1998, relevant research findings were formally published in the Journal of Biological Chemistry, confirming its non-cytotoxic profile and non-disruptive effect on normal melanocyte physiological functions, distinguishing it from destructive whitening agents.
Cosmetic Commercialization & Formulation Iteration (1999–2005)
In 1999, European and American biotechnology enterprises obtained patent licensing to commence mass commercial production of Nonapeptide-1 raw material, initially deployed primarily in basic facial whitening essence formulations.
By 2005, advances in transdermal delivery technology enabled Nonapeptide-1 compatibility with diverse matrices for eye care, makeup and hair care, completing its transformation from a single-function skincare raw material to a multi-functional cosmetic ingredient and ushering in an era of specialized segmented application.
Limitations & Functional Drawbacks
It only inhibits new melanin synthesis and cannot rapidly metabolize aged melanin already deposited on the skin surface; pairing with vitamin C or fruit acid derivatives is required for rapid spot fading.
Its relatively large molecular weight results in weak transdermal permeability in simple aqueous solutions; liposomes or polyol penetration enhancers are mandatory to fully deliver the active to melanocytes in the basal layer.
When used alone, its spot-fading speed lags behind high-potency tyrosinase inhibitors; compound formulation doubles its whitening efficacy.
HPLC Chromatographic Profile
Exclusive retention on reversed-phase C18 chromatographic column; detection wavelength set at 280 nm. For cosmetic-grade raw material, the main peak purity is ≥98.0%, and individual peptide impurity ≤2.0%. The acetate salt form of Nonapeptide-1 exhibits a slightly earlier elution time and superior water solubility.
Mass Spectrometric Characteristics
The dominant ESI mass spectrum peak is [M+H]⁺ = 1207.65, which serves as the marker for raw material identity verification. Oxidative impurities produce secondary peaks with mass shifts of +16 and +32, corresponding to mono-oxidized and di-oxidized methionine (Met) derivatives respectively.
Quality Control Specifications for Microbes and Heavy Metals
For lyophilized powder: endotoxin ≤50 EU/mg; total aerobic microbial count ＜10 CFU/mg. Free of Salmonella and Staphylococcus aureus. Contents of heavy metals including lead, arsenic, mercury and cadmium are far below the limits specified by national cosmetic standards, and the peptide shows no tendency to form heavy metal complexes.
References
- Cenexa Labs. Nonapeptide-1 Peptide Research – Complete Guide[EB/OL]. 2026.
- Jayawickreme C K. Melanocortin Receptor Antagonist Peptide Screening Experiment[J]. Journal of Biological Chemistry, 1998.
- Kopeptide Biotech. A New Whitening Solution for Sensitive Skin: Kopeptide Nonapeptide-1 Delivers Low-Irritation Long-Term Spot Fading with 1000 Da Macromolecules[EB/OL]. 2025.
- MedChemExpress. Nonapeptide-1 (Melanostatine-5) Product Technical Manual[EB/OL]. 2026.
- Sennopeptide. SNPep® NP-1 Nonapeptide-1 Raw Material Efficacy & Human Clinical Test Report[EB/OL]. 2026.
Hot Tags: nonapeptide-1 serum, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale